case_images: PMC10578418_01
case_images: (A and B) Photomicrographs from this case of the metastatic SFT which is composed of uniform fibroblastic spindle cells in a "patternless pattern" with a staghorn vasculature and myxoid background (H&E, 20x and 40x).
case_images: luad001f1.jpg
case_images: PMC10578418_01_luad001f1.jpg
case_images: luad001-F1
case_images: In August 2018, excisional biopsy of left supraclavicular and left inguinal masses were consistent with metastatic malignant meningeal SFT (Fig. 1A and 1B).
case_images: CT imaging of the abdomen and pelvis obtained after the administration of intravenous contrast material revealed a 5 x 5.4 x 18.2-cm lobulated mass infiltrating the left kidney, which was thought to be the putative source of IGF-2 excess.
case_images: luad001f2.jpg
case_images: PMC10578418_01_luad001f2.jpg
case_images: luad001-F2
case_images: CT scan of abdomen and pelvis in April 2022 revealed that the heterogeneous hypo-enhancing mass entirely replacing the left kidney now measured 11.6 x 10 x 28 cm (Fig. 2).
case_images: Dexcom G6 blood glucose reading data immediately before and 11 days after completion of palliative XRT.
case_images: luad001f3.jpg
case_images: PMC10578418_01_luad001f3.jpg
case_images: luad001-F3
case_images: By day 11 after finishing radiotherapy, the Dexcom G6 blood glucose readings showed that the hypoglycemia had abated and that postprandial hyperglycemia in the diabetic range was becoming evident (Fig. 3).